Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
about
Assistive technology, including orthotic devices, for the management of contractures in adult stroke patientsMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityNon-pharmacological interventions for caregivers of stroke survivorsSpotlight on botulinum toxin and its potential in the treatment of stroke-related spasticitySystematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticityCombined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled studyA randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairmentIncidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review.Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practiceThe adverse effect of spasticity on 3-month poststroke outcome using a population-based model.Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence?Quality of the stroke rehabilitation research.The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled TrialBotulinum toxin in clinical practicePhysical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment.Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial.Botulinum toxin type A combined with neurodynamic mobilization for lower limb spasticity: a case reportBotulinum toxin in poststroke spasticitySerial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.Botulinum toxin treatment of adult spasticity.Botulinum toxin type A for upper limb spasticity after stroke.Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications.Poststroke hypertonicity: upper limb assessment and treatment.Botulinum toxin A (Dysport®): in dystonias and focal spasticity.A literature review of the pathophysiology and onset of post-stroke spasticity.Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review.Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence.Enhancing patient-provider communication for long-term post-stroke spasticity management.Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Spasticity after stroke: physiology, assessment and treatment.Botulinum toxin for neuropathic pain and spasticity: an overview.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.
P2860
Q24197856-C10CBB9E-E177-4A39-ACD8-EC91FF3A843EQ24202197-152A31B1-42EF-48C5-AF5C-D6E8D9635258Q24203617-E0A5E100-6E64-4490-AC2E-CC7FAE9CFC71Q24236253-EB2BF8B3-26D8-457A-9ABA-31EEDE977964Q26750450-E3D55AE9-DE7D-4865-A50A-99D983A1D0D7Q26830501-FC2C03B6-D5C6-4681-B2F3-D748853CA61DQ28257329-65D531C2-C52F-4173-AC1D-4E8E6E8F5CBFQ28542828-6CDD7A98-1F37-43F5-9E02-4F9D16E03A17Q30252149-10747E94-128E-408E-857F-30BC7F7D10F7Q30538210-8AEF6F10-419D-4FBB-9D8E-476B3197C692Q34053123-FB235521-8CC7-4456-BB65-B56C5A87F1C6Q34579725-3AFF3180-9F6A-48B2-9162-EF8D19A4D27EQ35217428-B58E0E9E-BA67-4CC4-A47B-BD60A4A19F25Q35477882-8CC6A6B8-86EF-455C-8B7F-334C6016409EQ35478000-756A7778-3DDD-4935-8AB3-8C2B25B6D898Q35647787-875F0338-BE64-4958-B7C4-4BA394A4105DQ35807826-0B1A056B-C9A8-4F8E-A6F8-80416D874565Q36209475-84DB557F-AA17-41F1-8D7F-93C523A7694AQ36227094-5C7079E9-7470-445D-877A-DB87AFD1913CQ36482698-79CF1196-AC22-496C-85D4-B2B6F258371AQ36724869-571FDD99-1825-41D0-B8C4-08EF01F58B74Q36868342-10C49263-FE41-420C-8ECD-CCD725AB8BB5Q37011524-1E6965C1-E518-4892-AD68-6CBD9D1E70F3Q37032412-492C8BB7-0A14-477E-9223-6BB7AADCCA8AQ37089107-CCB9CAE7-9B7B-46BB-8A8A-CE8EB779B8C8Q37610190-EAA62180-9B1D-4771-AF2C-8900AE41BA77Q37641993-8C26485F-1604-4F7E-A05C-4BD74787E72AQ37825979-11C11326-DC20-42F6-B48C-F221D91020E8Q37885037-D2B40E46-7559-4A8A-A6C2-57D42968F6C9Q37888668-9FE26F84-05DA-4827-B4D2-0DA5E32E2AB1Q37894853-330B9C9A-8DC4-4BEC-8929-5750ACE7BDF3Q37939194-B38D10E0-926D-4AD7-A618-CC12890E8D35Q37995787-AC895395-B114-42FD-B69F-4FFC3B2A54C6Q38098126-FE6CF27C-3ACB-4311-807A-93922A669664Q38099673-467E14F1-0CAB-454E-BFF7-EDAFDB224DCDQ38102959-F1E541F5-706B-429A-9ABC-80E1598CEC7FQ38122349-E4993A25-2EC7-4E45-995C-DF10E2CEB115Q38124046-AF88D714-32B3-4331-ABA2-495AAC19042EQ38196928-35578C48-F06B-41EA-9FB6-831BB92EDEDFQ38263487-D3870654-082A-489A-9B28-48188992707C
P2860
Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Impact of botulinum toxin type ...... lind placebo controlled trial.
@ast
Impact of botulinum toxin type ...... lind placebo controlled trial.
@en
type
label
Impact of botulinum toxin type ...... lind placebo controlled trial.
@ast
Impact of botulinum toxin type ...... lind placebo controlled trial.
@en
prefLabel
Impact of botulinum toxin type ...... lind placebo controlled trial.
@ast
Impact of botulinum toxin type ...... lind placebo controlled trial.
@en
P2093
P2860
P356
P1476
Impact of botulinum toxin type ...... lind placebo controlled trial.
@en
P2093
Bamford JM
Chamberlain MA
P2860
P304
P356
10.1136/JNNP.69.2.217
P407
P577
2000-08-01T00:00:00Z